JAGSNPHARM — Jagsonpal Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹13.99bn
- IN₹13.01bn
- IN₹2.87bn
India's Jagsonpal Pharma rises after Q2 profit growth
Brief: Jagsonpal Pharmaceuticals Approves Sub-Division Of Shares
Brief: Jagsonpal Pharmaceuticals Launches Memup, A Bioidentical Hormone Replacement Therapy
Brief: Jagsonpal Pharmaceuticals Launches Queezy-Er®
Brief: Jagsonpal Pharmaceuticals March-Qtr Net Profit Rises
Brief: India's Jagsonpal Pharmaceuticals Dec-Quarter Net Profit Rises
Brief: India's Jagsonpal Pharmaceuticals Sept-Quarter Net Profit Rises
Brief: Jagson Pal Pharma Says Signs Agreement With Suvinys Developers For Supply Of Dydrogesterone
Sanjiv Kumar Dudeja Resigned As CFO
Brief: Jagson Pal Pharmaceuticals Sept-Qtr PAT Rises
Brief: Jagson Pal Pharmaceuticals Dec-Qtr Net Profit Rises
Brief: India's Jagson Pal Pharmaceuticals Dec Quarter Net Profit Rises
Brief: Jagson Pal Pharmaceuticals Sept-Quarter Net Profit Rises
Brief: India's Jagson Pal Pharmaceuticals Posts March Qtr Net Profit
Brief: India's Jagson Pal Pharmaceuticals Posts Dec-Qtr Profit
Brief: India's Jagson Pal Pharmaceuticals June-Qtr Net Profit 7.3 Million Rupees
Brief: India's Jagson Pal Pharma Posts Sept-Qtr Loss
Brief: India's Jagson Pal Pharmaceuticals posts June-qtr loss
Brief: Jagson Pal Pharmaceuticals Dec-qtr profit rises